Six-month real-world outcomes from the UP-RISING study: Patient beliefs in medicines and use of digital health applications in German patients with RA
Johannes Knitza, Patrizia Sternad, Daniel Bestler, Nicolai Steinchen et autres
Introduction: Upadacitinib (UPA) and TNF inhibitors (TNFi) are established therapies for patients with rheumatoid arthritis (RA) [ref:1], [ref:2], [ref:3], [ref:4], [ref:5], [ref:6], while digital health applications (DiGA) are relatively new [for full text, please go to the a.m. URL]
de (code pays fourni par la source)
0 citations
German Medical Science (German Research Foundation)